Oxford Science Enterprises welcomes Professor Dame Fiona Murray and Professor Sir Peter Donnelly as Non-Executive Directors

Oxford, UK – 19 June 2024 – Oxford Science Enterprises (OSE) today announces the appointment of Professor Dame Fiona Murray DCMG CBE and Professor Sir Peter Donnelly FRS FMedSci to its Board of Directors as independent Non-Executive Directors.

Chris Chambers, Chairman of the Board at OSE, said:

“I am delighted to welcome Fiona and Peter to OSE’s Board. They are both highly accomplished leaders in their respective fields who bring a wealth of experience in transforming visionary science into successful enterprises. Their insights will be invaluable in accelerating OSE’s mission of building companies tackling the world’s greatest challenges.”

Professor Dame Fiona Murray is Associate Dean of Innovation at the Massachusetts Institute of Technology (MIT) School of Management and Professor of Entrepreneurship. Recognised as an international policy expert on global innovation, she serves on the UK Prime Minister’s Council on Science and Technology and is on the Board of the newly formed NATO Innovation Fund. Fiona was awarded a CBE (Commander of the British Empire) and later appointed a DCMG (Dame Commander) for her contributions to science, technology, innovation and entrepreneurship.

Professor Dame Fiona Murray said:

“I am excited to join the Board of OSE and collaborate with the company’s leadership team to help OSE unlock its next stage of growth. OSE is at the forefront of transforming innovative ideas into commercial businesses, and it’s a great opportunity to be part of such a dynamic team and shape the next generation of impactful enterprises.”

Professor Sir Peter Donnelly is a leading statistician and geneticist, whose academic career has spanned four decades, latterly as Professor of Statistical Science and Director of the Wellcome Centre for Human Genetics at the University of Oxford. He was knighted in 2019 for services to the understanding of human genetics in disease, is a Fellow of the Royal Society and the Academy of Medical Sciences and has received numerous awards for his work.

Peter is also a successful entrepreneur, having co-founded and served as CEO of Genomics plc, an Oxford spinout harnessing large-scale genetic information to develop innovative precision healthcare tools and advance drug discovery.

Professor Sir Peter Donnelly said:

“I have seen first-hand the impact of the incredible science and entrepreneurial ecosystem being built at the University of Oxford. I am honoured to join the OSE Board and lend my experiences to help build the next generation of innovative companies creating meaningful change.”